Abediterol (napadisylate)

Abediterol napadisylate is an inhaled long-acting β2-adrenoceptor agonist (LABA) and can be used for the research of asthma and chronic obstructive pulmonary disease (COPD) [1].

Product Specifications

CAS Number

[1044516-17-7]

Product Name Alternative

AZD0548 (napadisylate) ; LAS100977 (napadisylate)

UNSPSC

12352005

Target

Adrenergic Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/abediterol-napadisylate.html

Smiles

O=S(O)(C1=CC=CC2=C1C=CC=C2S(=O)(O)=O)=O.FC(F)(C3=CC=CC=C3)COCCCCCCNC[C@@H](C4=C5C(NC(C=C5)=O)=C(C=C4)O)O.[0.5]

Molecular Formula

C25H30F2N2O4.1/2C10H8O6S2

Molecular Weight

604.66

References & Citations

[1]Ramos I, et al. Abediterol (LAS100977), an inhaled long-acting β2-adrenoceptor agonist, has a fast association rate and long residence time at receptor. European Journal of Pharmacology, 2018, 819: 89-97.